Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 12/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26139478 | 0.86 | ALDH1A1 (0.55) | GPR119USP2MAPTALDH1A1MEN1 | |
| SCHEMBL23051648 | 0.81 | GPR119 (0.55) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL20443678 | 0.81 | USP2 (0.63) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL14157779 | 0.81 | GPR119 (0.54) | GPR119MAPTLMNAALDH1A1MEN1 | |
| SCHEMBL5207933 | 0.80 | GPR119 (0.56) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL26139475 | 0.80 | USP2 (0.60) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL21679219 | 0.79 | GPR119 (0.53) | GPR119USP2ALDH1A1 | |
| SCHEMBL20046359 | 0.78 | GPR119 (0.52) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL20046615 | 0.78 | GPR119 (0.52) | GPR119USP2MAPTLMNAALDH1A1 | |
| SCHEMBL8159908 | 0.78 | MAPT (0.51) | GPR119USP2MAPTLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025011623-A1 | CYANOQUINOLINE-TARGETING PROTEIN DEGRADATION MOLECULE, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海壹迪生物技术有限公司 | 2025-01-16 | — | — | WO | disclosed |